Brief: Acurx Pharmaceuticals To Discuss Fourth Quarter And Full Year 2022 Financial Results And Provide Business Update
06/03/2023 13:21
March 6 (Reuters) - Acurx Pharmaceuticals Inc ACXP.O :
* ACURX PHARMACEUTICALS TO DISCUSS FOURTH QUARTER AND FULL
YEAR
2022 FINANCIAL RESULTS AND PROVIDE BUSINESS UPDATE
Source text for Eikon: ID:nPn5cTnkba
Further company coverage: ACXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acurx Pharmaceuticals
See all newsAcurx Pharmaceuticals Q1 net loss narrows as expenses fall
Brief: Acurx Pharmaceuticals To Discuss First Quarter 2026 Financial Results On May 12, 2026 Conference Call And Provide Business Update
Brief: Acurx Pharmaceuticals, Inc. Announces Closing Of Up To $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Acurx Pharmaceuticals Q4 net loss narrows on lower R&D spend
Acurx Pharma Q3 net loss narrows to $2 mln